Hematology

The department specializes in the diagnosis and management of various blood disorders, including anemia (low red blood cell count), thrombocytopenia (low platelet count), leukopenia (low white blood cell count), coagulation disorders (such as hemophilia and von Willebrand disease), and blood cancers (such as leukemia, lymphoma, and myeloma).

Hematology specialists utilize a range of diagnostic tests and procedures to evaluate blood cell counts, assess blood clotting function, detect abnormalities in blood morphology, and identify markers of hematologic diseases. Common tests may include complete blood count (CBC), peripheral blood smear, coagulation studies, bone marrow biopsy, and flow cytometry.

The department offers a variety of treatment modalities for hematologic conditions, including medications (such as blood thinners, immunosuppressants, and chemotherapy agents), blood transfusions, bone marrow transplantation, and supportive care interventions to manage symptoms and improve quality of life.

Hematology specialists are trained in the diagnosis and treatment of hematologic malignancies, including leukemia, lymphoma, and myeloma. They collaborate with oncologists and other multidisciplinary team members to develop personalized treatment plans based on disease subtype, stage, and patient-specific factors.

The department provides expertise in the management of thrombotic disorders (such as deep vein thrombosis and pulmonary embolism) and bleeding disorders (such as hemophilia and von Willebrand disease). This may involve anticoagulant therapy, antiplatelet therapy, and hemostatic agents to prevent or treat abnormal blood clotting or bleeding episodes.

Hematology specialists offer patient education and support to individuals with hematologic conditions and their families. They provide information on disease management, treatment options, potential side effects, lifestyle modifications, and resources for emotional and psychosocial support.